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Abstract
Background: Pregnant women residing in malaria endemic areas are highly susceptible to Plasmodium falciparum malaria,
particularly during their first pregnancy, resulting in low birth weight babies and maternal anaemia. This susceptibility is
associated with placental sequestration of parasitised red blood cells expressing pregnancy-specific variant surface
antigens. Acquisition of antibodies against these variant surface antigens may protect women and their offspring. Functions
of such antibodies may include prevention of placental sequestration or opsonisation of parasitised cells for phagocytic
clearance.
Methodology/Findings: Here we report the development and optimisation of a new high-throughput flow cytometry-
based phagocytosis assay using undifferentiated Thp-1 cells to quantitate the amount of opsonizing antibody in patient
sera, and apply this assay to measure the impact of HIV on the levels of antibodies to a pregnancy malaria-associated
parasite line in a cohort of Malawian primigravid women. The assay showed high reproducibility, with inter-experimental
correlation of r
2=0.99. In primigravid women, concurrent malaria infection was associated with significantly increased
antibodies, whereas HIV decreased the ability to acquire opsonising antibodies (Mann-Whitney ranksum: p=0.013). This
decrease was correlated with HIV-induced immunosuppression, with women with less than 350610
6 CD4+ T- cells/L having
less opsonising antibodies (coef: 211.95,P=0.002). Levels of antibodies were not associated with protection from low birth
weight or anaemia.
Conclusions/Significance: This flow cytometry-based phagocytosis assay proved to be efficient and accurate for the
measurement of Fc-receptor mediated phagocytosis-inducing antibodies in large cohorts. HIV was found to affect mainly
the acquisition of antibodies to pregnancy-specific malaria in primigravidae. Further studies of the relationship between
opsonising antibodies to malaria in pregnancy and HIV are indicated.
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Introduction
In malaria-endemic areas, pregnancy increases susceptibility to
infections by the malaria parasite Plasmodium falciparum. Pregnant
women with P. falciparum malaria are more likely to have low birth
weight (LBW) babies and to suffer from anaemia, especially during
their first pregnancy (reviewed in [1,2,3]). During pregnancy the
placenta expresses and exposes to the maternal blood circulation
chondroitin sulphate A (CSA) and this is one of the favoured
receptors for the binding of red cells infected with parasites
expressing pregnancy-associated variant surface antigens (VSA)
[4]. These VSA are parasite derived proteins expressed on the
surface of the parasitized red blood cells (pRBC). P. falciparum
erythrocyte membrane protein 1 (PfEMP1) is the most extensively
studied of the VSA, and acts as a major mediator of the parasite
sequestration and immune evasion that characterise P. falciparum
infections (reviewed in [5]). Identifying the determinants of
immunity to malaria in pregnancy is critical to understanding
the pathogenesis of the disease, and having a reliable and
convenient measure of protection from infection in pregnant
women who live in endemic regions is an important goal for local
and international public health authorities. The currently most
favoured measure of protection is antibodies that are directed
against pregnancy specific parasites. It is thought that the
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10807acquisition of antibodies against VSA expressed on the surface of
pRBC, over successive pregnancies, may protect the women and
their offspring [6,7]. In areas where HIV and malaria co-exist,
higher rates of malaria infection, higher densities and prevalence
of parasitaemia and lower levels of antibodies to pregnancy-
specific VSA are associated with HIV infection making the
combined presence of both HIV and malaria particularly
deleterious for the health of both mothers and newborns
[8,9,10,11,12].
Antibodies to pregnancy-associated VSA have previously been
measured by agglutination assays, anti-adhesion assays or assays
measuring IgG antibodies to pregnancy-associated VSA; more
recently the ability of these antibodies to induce phagocytic
clearance of pRBC (phagocytic antibodies) has been measured
(reviewed in [13], [11,14]). Antibodies that specifically contribute
to the phagocytosis of opsonised pRBC were shown to be
decreased in the serum of HIV-positive women [15].
Undifferentiated Thp-1 cells (uThp-1) are pro-monocytic cells
[16], shown to phagocytose IgG covered particles through Fcc
receptors [17]. The phagocytic response by Thp-1 cells correlates
with serum titres of IgG against VSA [14,18] and models using
adherent, chemically-differentiated Thp-1 cells (dThp-1) are useful
in evaluating antibodies as measures of protection in pregnant
women [11,14] but these assays are time-consuming and destroy
the effector cells. Also, in contrast to uThp-1, dThp-1 express
receptors such as CD36 that are able to promote non-Fc-receptor
mediated phagocytosis [19,20].
Here we present a new, easier and more high-throughput Thp-1
assay, using uThp-1 cells and flow cytometry. By performing this
new assay in parallel with an assay measuring the total levels of
VSA-specific IgG present in the serum, we determined the impact
of HIV on levels and function of antibodies towards the pregnancy
specific CSA-binding parasite-line CS2 in a cohort of primigravid
women.
Methods
Ethics statement
Ethical clearance for the study was provided by the College of
Medicine Research Ethics Committee, University of Malawi, and
the Melbourne Health Human Research Ethics Committee.
Study samples
The serum samples used in this assay came from a cohort which
has previously been described [11,21]. In brief, women in late
third trimester of pregnancy consented to studies including HIV
testing, and samples of peripheral blood were collected. Only
primigravid women were included in the present study, resulting
in a total of 263 samples analysed.
Placental tissue, collected at delivery, was fixed in formalin and
Giemsa stained sections were examined histologically as previously
described [22]. Placental malaria was considered to be present if
there was evidence of parasites or pigmented monocytes or
pigment in fibrin deposits in the placenta, irrespective of the
presence of parasites in the peripheral blood (unless stated
otherwise).
We combined histology findings with results of microscopy of
Giemsa-stained placental and peripheral blood thick films to
allocate women to one of four groups: No Malaria (no evidence of
past or current malaria, either in blood films or placental
histology), Acute Infection (pRBC on placental histology, without
malaria pigment deposition), Chronic Infection (both pRBC and
malaria pigment deposits on histology) and Past Infection (placental
malaria pigment deposits, without pRBC on histology or on blood
films). We excluded from the grouping analysis women who
presented only with peripheral parasitaemia. All infections were
with P. falciparum.
Maternal anaemia (anaemia) was defined as a haemoglobin
measurement of less than 11.0 g/dL. Infant low birth weight
(LBW) was considered to be a baby weight of less than 2,500 g.
Cell culture and Parasites
Thp-1 cells were maintained in RPMI 1640 (GIBCO) supple-
mented with 10% heat-inactivated Foetal Bovine Serum (FBS,
GIBCO), 1% penicillin-streptomycin (GIBCO), 2 mM Glutamine
(GIBCO), 25mM HEPES (GIBCO) and 55610
23 mM 2-Mer-
captho-Ethanol (SIGMA) at a density below 5610
5 cells/mL.
THP-1 cells were obtained from the ATCC (catalog number: TIB-
202
TM). THP-1 pro-monocytic cells were originally derived from a
patientwith monocyticleukemia [16]. Undifferentiated THP-1 cells
used in our assays had not been exposed to agents such as PMA
(phorbol-12-myristate-13-acetate) or TPA (12-O-tetradecanoyl-
phorbol-13-acetate) [23,24].
The CS2 parasite line is recognised as being similar to
placental-type isolates and known to bind to CSA and to be
recognised by serum in a pregnancy-specific and gravidity-
specific manner [25,26]. The parasite lines CS2 and CS2
transfected with a plasmid containing a green fluorescent protein
(GFP) expression cassette (Wilson et al. in preparation) were
maintained in RPMI-HEPES supplemented with 0.5% Albu-
maxII (GIBCO) and 25mM of NaHCO3 (parasite medium) and
gelatin selected (by flotation) every 2 weeks. The GFP expression
plasmid was maintained episomally by addition of 4ug/ml of
Blasticidin-S-HCL (Invitrogen) to CS2-GFP in continuous
culture. GFP expression was confirmed by staining pRBC
cultures with 10 mg/mL of Ethidium Bromide (EtBr, Bio-Rad
Laboratories) for 15 min at room temperature and comparing
EtBr fluorescence in the FL-2 channel with that of GFP in the
FL-1 channel using a FACSCalibur flow cytometer (BD
Biosciences).
Assays of IgG to CS2 VSA
IgG to CS2 VSA was measured as described by Mount and
colleagues [21] with minor modifications. In summary mid to late
trophozoite-stage CS2 pRBC at 3–10% parasitaemia were washed
thrice in PBS/1% newborn calf serum (PBS/NCS) by centrifuging
at 400 g for 5 minutes, resuspended at 0.1% haematocrit in PBS/
NCS, and incubated with test serum at 1/20 dilution for 30
minutes in a 96-well plate at RT. Cells were washed thrice. Rabbit
anti-human IgG (Dako) 1/100 in PBS/NCS was added and
incubated for 30 minutes at RT. After washing as before,
Alexafluor 488-conjugated donkey anti-rabbit IgG (Invitrogen)
was added at 1/500 dilution in PBS/NCS containing 10 mg/ml
EtBr and samples were incubated in the dark for 30 minutes at
RT. Cells were washed once again and resuspended in 150 ml PBS
before being analysed on a FACSCalibur flow cytometer. BD
CellQuest
TM software version 5.2.1 (BD Biosciences) was used to
acquire and analyse the data.
The RBC population was gated based on FSC and SSC.
CS2 pRBC were recognized by EtBr fluorescence and 1500
EtBr positive cells were acquired. The FL-1 Mean Fluores-
cence Intensity (MFI) above negative controls was used as a
relative measure of human IgG binding to pRBCs for each
serum sample. Samples were run in duplicate. Positive control
was a pool of serum with known high antibody recognition to
CS2. Negative controls were from six unexposed Australian
donors.
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a) The parasites. Mid- to late-trophozoite stage CS2-GFP
pRBC were purified by density gradient centrifugation. pRBC
were overlaid on a gradient of 80%, 60% and 40% Percoll
(Amersham) in parasite medium. After centrifugation at
2,000 g615 min, cells resting on the 60% layer were collected
and washed thrice at RT with RPMI-HEPES (400 g for 3 min).
Cells were resuspended at 5610
7/mL. In a 96-well u-bottom plate
previously coated with FBS, 3.3 mL of serum samples and dilutions
of a standard patient pooled serum (pps) were incubated with
30 mL of pRBC suspension and mixed. This included one well
with no serum sample (no-serum control) and one well with no
parasite (Thp-1 alone control). pRBC were opsonised by the
serum for 1 h at RT, in the dark and resuspended once, within
that hour. The cells were then washed thrice as before and
resuspended in 150 mL of Thp-1 medium. Following this 50 mL
were aliquoted into three wells of a final 96-well u-bottom plate.
b) Thp-1 cells. While the pRBC were being opsonised, Thp-
1 cells were collected, centrifuged at 300 g for 5 min at RT and
resuspended at 5610
5/mL in Thp-1 medium.
c) Phagocytosis. One hundred microliters of the Thp-1
suspension were dispensed into each well of the final plates which
contained 50 mLpRBCsuspension. Thecellsweremixed and leftto
phagocytosefor40 minat 37uC ina 5%CO2 humidifiedincubator.
Phagocytosis wasstoppedby centrifugation at 4uC, 350 g for3 min.
The supernatant was discarded and the cells were resuspended at
37uCi n1 5 0mL of FACS Lysing solution(BD Biosciences) at a 1/10
dilution in distilled water, and left at RT for 10 min in order to
eliminate unphagocytosed pRBC. Lysis was stopped by the addition
of 50 mL of cold PBS (2Ca
2+, 2Mg
2+) 2% FBS and 0.02% NaNO3
(FACS Buffer). The plates were centrifuged at 4uC, 350 g63 min.
After 3 washes with 150 mL of cold FACS Buffer at 4uC,
350 g63 min, the cells were fixed in cold 2% Paraformaldehyde
in PBS and left on ice before acquiring.
d) Flow Cytometry. Cells were acquired in a FACSCalibur
flow cytometer. Thp-1 cells alone were first gated on the basis of
their forward- and side-scatter properties. Their level of auto-
fluorescence in the FL-1 channel was set to always be less than 5%.
Sample triplicates were then acquired, usually at a rate of 250–
350 cells/s until 10,000 Thp-1 cells were acquired.
e) The analysis. All results were analysed using BD Cell-
Quest
TM software version 5.2.1. Triplicate results for samples and
standard curves were obtained after subtraction of the ‘‘Thp-1
alone’’ results. Using GraphPad Prism version 4.2 for Windows
(GraphPad Software, San Diego California USA), the means of
the triplicate standard curve phagocytosis results were plotted
against their dilution. The result was a saturation curve. After
natural log transformation of the x-axis, a standard curve was
obtained. Samples were then transformed in the same way, plotted
on the standard curve and transformed back in order to obtain
their relative titre.
Two parameters were obtained when using this assay:
1. The phagocytic antibodies’ function, measuring the percentage
of Thp-1 cells that phagocytosed pRBC compared to the
maximum percentage obtained in the standard curve (e.g. a
result of 30% Thp-1 cells positive on a sample compared to
60% Thp-1 cells positive using positive control serum would
give a 50% phagocytic activity);
2. The phagocytic antibodies’ titre, which like an ELISA,
compares the test sample to the standard curve of the positive
control to derive a relative titre of antibody (figure 1A and 1B).
Phagocytosis results higher than the standard curve, by the
nature of the assay, were discarded from the analysis.
Database analysis
Results for all the assays performed were combined in Stata v9.2
(StataCorp. 2005. Stata Statistical Software: Release 9. College Station,
TX: StataCorp LP), with a database containing the clinical
information on the study participants, and were statistically analysed
for the relevant study parameters. In some instances, stated in the
text, GraphPad Prism v 4.2 was used for statistical analyses.
Age, birth weight and maternal haemoglobin levels were all
normally distributed and Student’s t-tests were applied. Total IgG
to CS2 VSA, and phagocytic antibodies were not normally
distributed and were analysed using Mann-Whitney rank sum
tests. All other variables were categorical. Multiple linear
regression models were used to seek correlations between
continuous and categorical variables.
Results
Undifferentiated Thp-1 cells present several advantages
to the commonly used differentiated Thp-1 cells assay
Several advantages were found associated with the uThp-1
assay compared to the commonly used dThp-1 assay, as
summarized in table 1. This assay was faster, and specifically
measured Fc-receptor mediated phagocytosis. Phagocytosis per-
formed by uThp-1 varied in proportion to the amount of antibody
bound to the target (figures 1A and 1B), and increased
exponentially, following a sigmoidal curve, once the data were
transformed. Consistency of results between different assays, on
different days was high (figure 1C): intra-assay variability was
minimal, with linear correlation between triplicates of serum
samples run in the same day always high (r
2.0.98).
Phagocytic antibodies’ function in this cohort revealed
the largest value spread and correlates with total amount
of IgG to CS2 VSA
Both the titre and the function of phagocytic antibodies
correlated with levels of IgG to CS2 VSA (Spearman’s rank
correlation rho=0.48 and 0.50 respectively, p,0.0001) but, when
a linear regression was performed, correlation between function of
phagocytic antibodies and IgG to CS2 VSA (r
2=0.56) was
stronger than the one found between titres and IgG to CS2 VSA
(r
2=0.41) owing to their spread over a larger range of values
(figure 2A and 2B). For further analysis, we used the function of
the phagocytic antibodies and referred to the titre only where
significant differences between the two parameters occurred.
HIV and P. falciparum infections are independently
associated with maternal haemoglobin levels, maternal
anaemia, infant birth weight and low birth weight
In a univariate analysis (table 2), both HIV and P. falciparum
infection significantly decreased maternal haemoglobin levels and
infant birth weight. The age of the women was significantly
associated with both P. falciparum infection (being higher in
uninfected women) and HIV (being higher in infected women).
Women that were co-infected with HIV and P. falciparum had
lower birth weight babies and presented with lower levels of
haemoglobin than other groups (table 2).
When age, HIV status and P. falciparum malaria status were
included in a multivariate analysis, both haemoglobin levels (HIV:
coef=21.1, P=,0.0001; malaria: coef=20.8, P=0.002) and
birth weight (HIV: coef=2238.7, P=,0.0001; malaria:
coef=2193.7, P=0.002) were decreased by both infections.
With each of the infections, there was an increase in the
prevalence of anaemia (HIV: coef=0.19, P=,0.003; malaria:
Pregnancy-Malaria Antibodies
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malaria: coef=0.10, P=0.028), although the significance of the
LBW prevalence increase with HIV was marginal.
IgG to CS2 VSA and phagocytic antibodies are increased
in P. falciparum -infected women and decreased in HIV-
infected women
In a univariate analysis (Mann-Whitney ranksum), both
phagocytic antibodies (Phago atb) and IgG to CS2 VSA (Total
IgG) were higher in women with P. falciparum infection (Phago atb:
z=6.08, P,0.0001; Total IgG: z=4.83, P,0.0001) and lower in
HIV infected women (Phago atb: z=23.75, P=0.0002; Total
IgG: z=22.70, P=0.007). Maternal haemoglobin levels and
infant birth weights were not found to be associated with changes
of IgG to CS2 VSA or phagocytic antibodies (table 3), and neither
were the outcomes anaemia and LBW (data not shown).
In a multivariate analysis, using multiple linear regression
methods, on P. falciparum positive women, HIV infection was
associated with decreased phagocytic antibodies, but neither
Table 1. Main differences between new phagocytosis method and the common method used.
New assay Commonly used assay
Undifferentiated Thp-1 assay Differentiated Thp-1
Cells plated and used in the same day Cells plated, stimulated and used 3 days later
Cells in suspension Cells are adherent
56 Samples per 1 day/Assay (triplicate) 36 Samples per 3 day/Assay (triplicate)
Fluorescence based Assay – FACS Colorimetric based assay- Elisa reader
Read-out: Percentage of phagocytic cells that have ingested labelled pRBC Read-out: Amount of haemoglobin released by lysis of phagocytic cells
Possibility of including other parameters (e.g. cell surface markers) Only one parameter measured
Phagocytic cells readily accessible for further studies Phagocytic cells destroyed
Phagocytosis almost exclusively via Fc-receptors Phagocytosis through various receptors/mechanisms
Comparison between phagocytosis assay done using undifferentiated Thp-1 cells (used in this study) and chemically- differentiated Thp-1 cells.
doi:10.1371/journal.pone.0010807.t001
Figure 1. Phagocytosis profile of a typical uThp-1 phagocytosis assay standard curve and inter-assay reproducibility. A) Typical
standard curve plot of percentage of patient pooled serum against percent of GFP-positive uThp-1 cells with indications of absolute phagocytosis
values used for phagocytic antibodies’ function, titre and both the titre range obtained in this study (PTR) and a theoretical titre range (TTR)
(extrapolated from the patient pooled serum titre). B) Typical transformation of standard curve results. X-axis is the natural logarithm (ln) of the
patient pooled serum. Goodness of fit: r
2=0.99. For all standard curves r
2 was always higher than 0.97. C) Correlation of results obtained on different
experimental days. CS2 –GFP RBC opsonised with increasing dilutions of pooled patient serum were incubated with uThp-1 cells for 40 min and
phagocytosis was measured by flow cytometry. The absolute phagocytosis values obtained on both experimental days are plotted. A dilution of 1/10
of original serum was always considered as the 100%. No-serum control would be assigned an arbitrary value of 9610
28%. uThp-1 cells alone were
considered absolute zero. Analysis performed on GraphPad Prism v4.0
doi:10.1371/journal.pone.0010807.g001
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impacted on IgG to CS2 VSA (table 3).
When the multivariate analysis included both P. falciparum-
positive and P. falciparum -negative women both IgG to CS2 VSA
and phagocytic antibodies were found to be associated with HIV
(Table S1). No associations were found between HIV positivity
and antibody levels in P. falciparum-negative women only (data not
shown).
IgG to CS2 VSA and function of phagocytic antibodies
across the different histopathology groups are differently
modulated by HIV infection
When analysis of antibody measurements was made according
to the placental malaria status of the women, similar levels of both
VSA IgG and phagocytic antibodies were observed in the groups
with current or previous P. falciparum infection and no HIV
(figure 3, light grey bars).
When HIV positive women were analysed with regard to their
antibody measurements (figure 3, dark grey bars), women in the
acute infection group had significantly lower IgG to CS2 VSA
levels than women in the combined chronic and past groups
(Mann-Whitney ranksum: p=0.018 and p=0.038, respectively,
figure 3A) and significantly lower phagocytic antibodies function
than women in the chronic group (Mann-Whitney ranksum:
p=0.034, figure 3B).
The comparison between antibody measurements in HIV
positive and HIV negative women in the different histopathology
groups revealed that HIV positive women in the acute group failed
to generate antibodies to pRBC, both total (Mann-Whitney
ranksum: p=0.028, figure 3A) and phagocytic (Mann-Whitney
ranksum: p=0.013, figure 3B), when compared to the HIV
Figure 2. Distribution of, and correlation between, antibody parameters measured. A) Dot plot representation of the distribution of
values obtained for VSA IgC to CS2, and both phagocytic antibodies’ parameters. n= number of samples analysed in each group. B) linear regression
analysis of VSA IgG to CS2 and both function (open squares) and titre (full triangles) of phagocytic antibodies. Analysis performed on GraphPad Prism
v4.0
doi:10.1371/journal.pone.0010807.g002
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infection group had similar levels of antibodies. HIV infected
women in the past infection group had lower levels of phagocytic
antibodies than did HIV negative women in this group (Mann-
Whitney ranksum: p=0.07).
Peripheral blood CD4 T-cell counts appeared to be correlated
with levels of antibody to pRBC. HIV positive women who
presented with a CD4-T cell count less than 350610
6 cells/L had
lower levels of IgG to CS2 VSA (coef: 26.15, P=0.007) and less
phagocytic antibodies (coef: 211.95,P=0.002) than did HIV
infected women with CD4 T-cell counts above 350610
6 cells/L.
Discussion
Undifferentiated Thp-1 cells had previously been shown to be
useful when measuring erythrophagocytosis [27], but no high-
throughput assay concerning Fc-mediated phagocytosis that could
actually be used consistently on large sample sets existed. In this
study an improved, high-throughput method has been developed
in order to more accurately and rapidly estimate Fc-receptor
mediated phagocytosis induced by P. falciparum malaria-specific
antibodies. Such a method facilitates the measurement of
functional antibodies to malaria VSA in large sample sets. Based
on the use of undifferentiated Thp-1 cells that grow in suspension,
this assay lends itself to various small modifications that might be
used to study both the effector cell response to pRBC expressing
specific ligands, and the antibody responses to these pRBC. In
comparison with the dThp-1 cells assay that has been more widely
used [11,14,21], there are various advantages (table 1). The use of
standard curves allows the immediate comparison of the behaviour
of the uThp-1 across different experimental days and also is an
assurance of inter-assay consistency of results. Undifferentiated
Thp-1 cells are also of particular interest in the study of phagocytic
antibodies since it is clear that the IgG-mediated phagocytosis
performed by these cells is through Fcc receptors I and II, the only
Fcc receptors present in these cells [17]. Of note, uThp-1 cells do
not express CD36 [19] a known cell-membrane receptor that can
promote phagocytosis of unopsonised pRBC [20]. uThp-1 cells
were unable to phagocytose unopsonised pRBC of the CD36-
binding parasite line 3D7, and also, although uThp-1 express
CD54 (ICAM-1), the CD54-binding parasite line E8B-ICAM did
not trigger a phagocytic response in the absence of immune serum
(authors’ unpublished data), demonstrating that this cytoadher-
ence ligand is not involved in uThp-1-mediated phagocytosis. The
assays reported here were performed using GFP expressing
parasites and uThp-1 cells, but the assay can be adapted to use
EtBr stained parasites and positively selected donor monocytic
cells (authors’ unpublished data), which permit the measurement
of responses against multiple parasite lines, and to study variation
in host phagocytic cell responses.
Levels of IgG to CS2 VSA as well as function elicited by
phagocytic antibodies had a larger spread than the actual titre of
the phagocytic antibodies observed, and we postulate that this is
due to the limited exposure of primigravidae in this study to
pregnancy specific parasites. In cohorts of multigravid women,
with greater histories of exposure and more developed pregnancy-
specific immunity, titres of phagocytic antibodies may have a
larger spread, and may thus be more informative. The choice of
function or titre for analysis is dependent on the research question,
though both parameters can provide valuable information.
Both HIV and malaria were strongly and independently
associated with the occurrence of low maternal haemoglobin
and lower birth weight babies, and as expected, co-infected
women and their babies had the worst outcomes [9,28]. Levels of
IgG to CS2 VSA and phagocytic antibodies were lower in HIV
positive women when compared to HIV negative women and
higher in women with malaria infection when compared to
women without malaria infection. In our cohort of primigravidae,
antibodies were not found to be associated with protection from
anaemia or LBW (known to be important outcomes associated
with placental malaria (reviewed in [3,29]), instead antibodies
reflect mainly exposure to antigen. Similar results, with a lack of
association between adverse outcomes and presence of antibodies
to malaria in pregnancy related antigens, have recently been
published [30]. It may be possible that a certain titre and ‘‘quality’’
of such antibodies has to be present in circulation at very early
stages during the pregnancy for a protective effect (or an
association with one) to be observed, something already suggested
by other studies [7,30,31]. In a multivariate analysis including
HIV, maternal haemoglobin level and infant birth weight, using
Table 2. Associations of HIV and malaria infections in the cohort.
Age Maternal Hb level (g/dL)
1 Infant Bw (g)
2
n [%] Mean (SD) p-value n [%] Mean (SD) p-value n [%] Mean (SD) p-value
Entire Cohort 263 [100] 20.0 (3.3) 258 [100] 11.3 (1.98) 224 [100] 2904 (444)
HIV negative 156 [60] 19.5 (2.7) 155 [60] 11.6 (1.96) 123 [55] 2982 (413)
positive 106 [40] 20.7 (3.9) 0.007 102[40] 10.8 (1.93) 0.002 100 [45] 2808 (466) 0.003
Malaria infection negative 104 [41] 20.7 (3.6) 152 [60] 11.5 (1.91) 101 [45] 2978(416)
positive 151 [59] 19.6 (2.7) 0.0075 98 [40] 10.9 (2.00) 0.013 121[54] 2845(464) 0.016
Histology not present 8 [3]
HIV and Malaria:
DOUBLE NEGATIVES
3 43 [16] 19.6 (2.8) 43 [16] 12.1 (1.66) 40 [18] 3158 (402)
DOUBLE POSITIVES
4 42 [16] 19.8 (3.0) 0.77 42 [16] 10.3(1.96) ,0.0001 41 [18] 2726 (559) 0.0001
Data represents means (standard deviation from means), and numbers of subjects [percent of total for each parameter].
1Maternal haemoglobin levels.
2Birth weight of babies at delivery.
3DOUBLE NEGATIVES are women with neither HIV nor malaria.
4DOUBLE POSITIVES are women with both HIV and malaria infection. Variables are normally distributed, so Student’s t-tests were applied. Variables were analysed for all
subjects for whom the relevant data were recorded.
doi:10.1371/journal.pone.0010807.t002
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a decrease of phagocytic antibodies function but not of levels of
IgG to CS2 VSA. A similar result with HIV affecting phagocytic
antibodies function (opsonic-activity) but not other types of
antibody was obtained by Jaworowski et al, using multigravid
women from this same study cohort [11]. HIV may therefore
impact differently on the production of functionally distinct
antibodies (as suggested also by [15]).
When the women were grouped according to their placental
malaria status, measures of the function of phagocytic antibodies
and the total IgG to CS2 VSA tended to vary between current,
chronic and past placental infection, although differences only
reached statistical significance in HIV positive women. Anti-
body levels were highest in the women with chronic infection (as
observed by others [6]), supporting the view that constant
exposure to the parasite increases production of antibody.
Unlike the previous study, which included women of all
gravidities, we focussed solely on primigravidae, indicating that
in a single pregnancy, chronic infection leads to strong anti-VSA
antibody responses. In the absence of HIV infection, the levels
of antibody in acute infection were very similar to those in
chronic infection, suggesting that robust antibody responses to
these antigens can develop rapidly, as observed also in other
studies [31]. Further investigation of the relationship between
placental histopathology, duration of infection and levels of
antibodies in HIV positive versus HIV negative women would
be of significant interest in confirming the differences we have
observed.
Grouping according to placental malaria status provides also a
putative timeline of exposure to pregnancy specific antigens and of
antibody acquisition: Women with No Malaria may have had little
or no exposure to antigen. In Acute Infection, antibody responses
are developing, following recent exposure to antigen. Chronic
Infection represents repeated exposure to antigen, and antibody
maturation and/or recall, and Past Infection is associated with
antibody maintenance, following past exposure to antigen. This is
Table 3. Association between indicated characteristics and PiAs function or IgG to CS2 VSA.
Phagocytic
function Univariate analysis
1 Multivariate analysis
2
Variables n % Z or Coeff (95% CI) P Coeff (95% CI) P
TOTAL 263 100
Plac malaria
Negative 104 39.54
Positive 151 57.41 6.08 ,0.0001 NA
Histology not
present
8 3.04
HIV
Negative 157 59.70
Positive 106 40.30 23.75 0.0002 210.97 (221.33, 20.61) 0.038
Hemoglobin levels
3 Present 261 99.24 27.31 (22.25, 0.781) 0.342 20.99 (23.36, 1.39) 0.412
Unknown 2 0.76
Infant Birthweight
3 Present 227 86.31 20.004 (20.011, 0.03) 0.227 0.001 (20.009, 0.012) 0.834
Unknown 36 13.69
IgG to CS2 VSA Univariate analysis Multivariate analysis
Variables n % Z or Coef (95% CI) P Coefficient (95% CI) P
TOTAL 234 100
Plac malaria
Negative 91 38.89
Positive 137 58.55 4.83 ,0.0001 NA
Histology not
present
6 2.56
HIV
Negative 141 60.26
Positive 93 39.74 22.74 0.0007 27.60 (216.9, 1.68) 0.107
Hemoglobin levels Present 233 41.45 20.455 (21.72, 0.80) 0.477 20.56 (22.90, 1.78) 0.637
Unknown 1 0.43
Infant Birthweight Present 202 10.68 20.003 (20.009,0.004) 0.400 0.002 (20.008, 0.012) 0.708
Unknown 32 13.68
1Function of phagocytic antibodies (top) and IgG to CS2 VSA (bottom) unadjusted analysis (Mann-Whitney Ranksum for HIV and Malaria infections with Z-statistic score
and Linear Regression analysis for Maternal haemoglobin levels and Infant birth weight with coefficients and 95% confidence intervals. P-values are also shown).
2Adjusted estimate for malaria positive women only (Multi linear model correlation coefficients and respective 95% confidence intervals and P-values are shown). (n)
number of women (NA) non-applicable (Z) Z-statistic (coeff (95% CI)) correlation coefficient and 95% confidence intervals. A negative Z-statistic or coefficient implies a
decrease of antibody levels. A positive Z-statistic or coefficient implies an increase in antibody levels.
doi:10.1371/journal.pone.0010807.t003
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placental infection [32].
This classification seems to suggest that HIV infection reduced
the generation of antibodies and possibly affected the maintenance
of antibodies after clearance of malaria infection, when comparing
HIV-positive with HIV-negative women. The time-frame of one
pregnancy is probably not ample enough to fully assess the impact
that HIV can have on the maintenance of antibody repertoires,
but it is well established that HIV negatively influences memory B
cells, impairing the long-term serological memory of the infected
individuals [33,34]. Future studies looking at the levels of these
same antibodies 6 months after delivery or in subsequent
pregnancies in HIV-negative and HIV- positive women and
comparing numbers and activity of memory B-cells may prove to
be more informative.
In the chronic infection group, HIV did not seem to impact on
the level of IgG to CS2 VSA or function of these antibodies,
suggesting that greater exposure may overcome the impairment in
antibody production elicited by HIV infection. Despite levels of
antibody that may seem sufficient, HIV infected women may lack,
or have impaired, phagocytic cells that would respond to these
antibodies, making the evaluation of the capacity of these women’s
effector cells in responding to opsonised targets a major area of
interest.
Figure 3. Antibodies across histopathology groups of placental malaria. Antibody measurements across histopathology of placental
malaria groups. Light grey bars – HIV negative (HIV2), dark grey bars – HIV positive (HIV=). A) Total VSA IgG to CS2. Mann-Whitney ranksum tests
performed on HIV2 women: 1acute vs chronic p=0.018, { acute vs past: p=0.038. Mann-Whitney ranksum tests performed between HIV2 and HIV+
women: * acute group: p=0.028. B) phagocytic antibodies’ function. Mann-Whitney ranksum tests performed on HIV- women: 1 acute vs chronic
p=0.034. Mann-Whitney ranksum tests performed between HIV2 and HIV+ women: * acute group: p=0.013, { past group: p=0.07. Bars represent
median and interquartile ranges. Whiskers represent 95% CI. Dots represent outliers.
doi:10.1371/journal.pone.0010807.g003
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PLoS ONE | www.plosone.org 8 May 2010 | Volume 5 | Issue 5 | e10807In summary, a new assay to measure the activity of phagocytic
antibodies was developed and revealed to be high throughput and
reproducible, making it ideal to investigate these antibodies in
large sample sets. By applying the assay to a cohort of primigravid
women, which are the most susceptible group to suffer from the
deleterious effects of placental malaria, we have shown that
primigravidae can exhibit a strong antibody response to
pregnancy-specific parasites which can be measured through the
use of their serum to opsonise and subsequently promote the
uptake of CS2 pRBC. These antibodies correlate with exposure to
pregnancy-specific parasites and with levels of IgG to VSA of the
placenta-like parasite strain CS2, although these responses do not
appear to protect against complications of pregnancy malaria in
first pregnancy. By grouping the women according to a putative
time-line of exposure to the parasite we were able to see the effect
that HIV has on the acquisition of antibodies and, possibly, on
their maintenance. Interestingly, in a multivariate analysis of
malaria positive women, HIV infection significantly impaired
phagocytic antibodies but not levels of IgG to CS2 VSA. It is
unusual for studies to focus only on primigravid women due to
their limited range of antibodies. Despite that fact, in this study our
protocol allowed us not only to measure biologically functional
antibodies, but also relate them to HIV status and even placental
malaria status. From this, we conclude that women in their first
pregnancy are able to mount a phagocytic antibody response to
pregnancy specific malaria parasites that may be important for
subsequent pregnancies, and that this response can be severely
modulated in the presence of HIV. These findings may prove to be
important in the context of developing vaccines towards malarial
antigens in areas where HIV has a considerable impact.
Supporting Information
Table S1 Multivariate analysis on all women of the association
between indicated characteristics and PiAs function or IgG to CS2
VSA. Function of phagocytic antibodies (top) and IgG to CS2
VSA (bottom) adjusted estimates for malaria positive and negative
women (Multi linear model correlation coefficients and respective
95% confidence intervals and P-values are shown). (n) number of
women (NA) non-applicable (coeff (95% CI)) correlation coeffi-
cient and 95% confidence intervals. A negative coefficient implies
a decrease of antibody levels. A positive coefficient implies an
increase in antibody levels.
Found at: doi:10.1371/journal.pone.0010807.s001 (0.06 MB
DOC)
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